Late-pregnancy maternal serum alkaline phosphatase levels and risk of early postpartum cardiometabolic disease: A municipality-wide electronic health record-based cohort study in Tianjin, China.
Lower alkaline phosphatase levels during pregnancy may help doctors identify women at higher risk for heart and metabolic problems after delivery.
This retrospective electronic health record cohort study examined late-pregnancy maternal serum alkaline phosphatase levels and risk of early postpartum cardiometabolic disease: a municipality-wide electronic health record-based cohort study in tianjin, china. The abstract reports that lower gestational age-standardized maternal ALP levels before delivery were associated with a higher risk of early postpartum cardiometabolic disease.
What the study was
- Study design
- Retrospective electronic health record cohort study
- Category
- Public Health
- Maturity
- Validated
- Journal
- Preventive medicine
Why it surfaced
Retrospective electronic health record cohort study relevant to Cardiovascular-metabolic: GLP-1, SGLT2, cardiometabolic risk; score assigned conservatively from the PubMed abstract and metadata.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.